Chemical Hypoxia-induced Glucose Transporter-4 Translocation in Neonatal Rat Cardiomyocytes

Archives of Medical Research

Volumn 39, Issue 1, 2008, Pages 52-60

  Guan, Fu ^a   Yu, Bo ^a   Qi, Guo xian ^a   Hu, Jian ^a   Zeng, Ding yin ^a   Luo, Jia ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

AMP activated protein kinase; Azide; Cardiomyocyte; Glucose transporter 4; Hypoxia

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; AZIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; VIDARABINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE TRANSLOCATION; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HYPOXIA; NEWBORN; NONHUMAN; RANDOMIZATION; RAT; RAT STRAIN; WESTERN BLOTTING;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; ANIMALS, NEWBORN; CELL HYPOXIA; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; MULTIENZYME COMPLEXES; MYOCYTES, CARDIAC; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; RIBONUCLEOTIDES; SODIUM AZIDE;

EID: 36549058703     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.06.022     Document Type: Article

References (42)

1. Thong F.S., Dugani C.B., and Klip A. Turning signals on and off: GLUT4 traffic in the insulin-signaling highway. Physiology 20 (2005) 271-284
2. Fischer Y., Kamp J., Thomas J., Popping S., Rose H., Carpene C., et al. Signals mediating stimulation of cardiomyocytes glucose transport by the alpha-adrenergic agonist phenylephrine. Am J Physiol 270 (1996) C1211-C1220
3. Eblenkamp M., Bottcher U., Thomas J., Loken C., Ionescu I., Rose H., et al. The effect of anoxia on cardiomyocytes glucose transport does not involve an adenosine release or a change in energy state. Life Sci 59 (1996) 141-151
4. Egert S., Nguyen N., Brosius III F.C., and Schwaiger M. Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts. Cardiocasc Res 35 (1997) 283-293
5. Coven D.L., Hu X., Cong L., Bergeron R., Shulman G.I., Hardie D.G., et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am J Physiol Endocrinol Metab 285 (2003) E629-E636
6. Chen J., Hudson E., Chi M.M., Chang A.S., Moley K.H., Hardie D.G., et al. regulation of mouse oocyte meiotic resumption in vitro. Dev Biol 15 (2006) 291:227-238
7. Shu J.C., Bradley M.E., and Te C.L. Chemical hypoxia triggers apoptosis of cultured neonatal rat cardiac myocytes: modulation by calcium-regulated proteases and protein kinase. Mol Cell Biochem 178 (1998) 141-149
8. Yu B., Poirier L.A., and Nagy L.E. Mobilization of GLUT-4 from intracellular vesicles by insulin and K1 depolarization in cultured H9c2 myotubes. Am J Physiol Endocrinol Metab 277 (1999) E259-E267
9. Herman G.A., Bonzelius F., Cieutat A.-M., and Kelly R.B. A distinct class of intracellular storage vesicles, identified by expression of the glucose transporter GLUT-4. Proc Natl Acad Sci USA 91 (1994) 12750-12754
10. Lecoeur H., Fevrier M., Garcia S., Riviere Y., and Gougeon M.L. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 253 (2001) 177-187
11. Beeson M., Sajan M.P., Dizon M., Grebenev D., Gomez-Daspet J., Miura A., et al. Activation of protein kinase C-ζ by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise. Diabetes 52 (2003) 1926-1934
12. Xing Y., Musi N., Fujii N., Zou L., Luptak I., Hirshman M.F., et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative α2 subunit of AMP-activated protein kinase. J Biol Chem 278 (2003) 28372-28377
13. Brancho D., Tanaka N., Jaeschke A., Ventura J.J., Kelkar N., Tanaka Y., et al. Mechanism of p38 MAP kinase activation in vivo. Genes Dev 17 (2003) 1969-1978
14. Young L.H., Li J., Baron S.J., and Russell R.R. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 15 (2005) 110-118
15. Mu J., Brozinick Jr. J.T., Valladares O., Bucan M., and Birnbaum M.J. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7 (2001) 1085-1094
16. Merrill G.F., Kurth E.J., Hardie D.G., and Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273 (1997) E1107-E1112
17. Stein S.C., Woods A., Jones N.A., Davison M.D., and Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 3 (2000) 437-434
18. Kumar D., and Jugdutt B.I. Apoptosis and oxidants in the heart. J Lab Clin Med 142 (2003) 288-297
19. Przygodzki T., Sokal A., and Bryszewska M. Calcium ionophore A23187 action on cardiac myocytes is accompanied by enhanced production of reactive oxygen species. Biochim Biophys Acta 1740 (2005) 481-488
20. Davidson S.M., and Duchen M.R. Effects of NO on mitochondrial function in cardiomyocytes: pathophysiological relevance. Cardiovasc Res 71 (2006) 10-21
21. Tavernarakis N. Cardiomyocyte necrosis: alternative mechanisms, effective interventions. Biochim Biophys Acta 1773 (2007) 480-482
22. Ver Donck L., Gorgers M., and Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res 27 (1993) 349-357
23. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184 (1995) 39-51
24. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., and van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84 (1994) 1415-1420
25. Eray M., Matto M., Kaartinen M., Andersson L., and Pelkonen J. Flow cytometric analysis of apoptotic subpopulations with a combination of annexin V-FITC, propidium iodide, and SYTO 17. Cytometry 43 (2001) 134-142
26. Chiang S.H., Baumann C.A., Kanzaki M., Thurmond D.C., Watson R.T., Neudauer C.L., et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410 (2001) 944-948
27. Makoto K. Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr J 53 (2006) 267-293
28. Farese R.V., Sajan M.P., and Standaert M.L. Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans 33 (2005) 350-353
29. Welsh G.I., Hers I., Berwick D.C., Dell G., Wherlock M., Birkin R., et al. Role of protein kinase B in insulin-regulated glucose uptake. Biochem Soc Trans 33 (2005) 346-349
30. Bae S.S., Cho H., Mu J., and Birnbaum M.J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278 (2003) 49530-49536
31. Russell III R.R., Bergeron R., Shulman G.I., and Young L.H. Translocation of myocardial GLUT4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 277 (1999) H643-H649
32. Li J., Hu X., Selvakumar P., Russell III R.R., Cushman S.W., Holman G.D., and Young L.H. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol 287 (2004) E834-E841
33. Pelletier A., Joly E., Prentki M., and Coderre L. Adenosine 5′-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes. Endocrinology 146 (2005) 2285-2294
34. Tong H., Chen W., London R.E., Murphy E., and Steenbergen C. Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase. J Biol Chem 275 (2000) 11981-11986
35. Tong H., Chen W., London R.E., Murphy E., and Steenbergen C. AMP-activated protein kinase activates p38 mitogen-activated protein kinase by increasing recruitment of p38 MAPK to TAB1 in the ischemic heart. Circ Res 97 (2005) 872-879
36. Tanno M., Bassi R., Gorog D.A., Saurin A.T., Jiang J., Heads R.J., et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93 (2003) 254-261
37. Perrini S., Henriksson J., Zierath J.R., and Widegren U. Exercise-induced protein kinase C isoform-specific activation in human skeletal muscle. Diabetes 53 (2004) 21-24
38. Chen H.C., Bandyopadhyay G., Sajan M.P., Kanoh Y., Standaert M., Farese Jr. R.V., et al. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxyamide-1-β-D-ribofuranoside (AICAR) stimulated glucose transport. J Biol Chem 277 (2002) 23554-23562
39. Kramer H.F., Witczak C.A., Fujii N., Jessen N., Taylor E.B., Arnolds D.E., et al. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55 (2006) 2067-2076
40. Cho H., Thorvaldsen J.L., Chu Q., Feng F., and Birnbaum M.J. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276 (2001) 38349-38352
41. Pozuelo Rubio M., Peggie M., Wong B.H., Morrice N., and MacKintosh C. 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase. EMBO J 22 (2003) 3514-3523
42. Bruss M.D., Arias E.B., Lienhard G.E., and Cartee G.D. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54 (2005) 41-50